John Vandermosten: Cancer Therapy Idea Merck
136 views · Published 30 October 2018 · 7:49 · Indexed 23 September 2026
Channel: MoneyShow · 2018 · Education
At MoneyShow Dallas, John Vandermosten of Zacks Investment Research: one area that's been big in cancer drugs has been checkpoint inhibitors, such as Keytruda from Merck. They work well in about 20% of the people in caner therapy, he tells interviewer Kelley Wright of IQTrends.com.
More from this channel
-
7:48
Commonly Used Moving Averages with Greg Capra
-
2:43
How To Build Confidence in Trading
-
2:46
Trading with Price Action Analysis
-
3:45
Indicators of a Trading Pro
-
43:21
Oil Crash Investing: Separating the Safe from Dangerous MLPs
-
54:31
Tactical Investment Strategies for 2015 and 2016
-
1:40
Trading Outlook for Today: October 25, 2016
-
48:19
Biotech Takeover: Successfully Identifying and Profiting from Biotech Buyout Targets